Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|May 28, 2020
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastomaDipongkor Saha, Samuel D Rabkin, Robert L MartuzaCancer Cell|August 16, 2017
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint BlockadeDipongkor Saha, Robert L Martuza, Samuel D RabkinBiorxiv : the Preprint Server for Biology|November 24, 2025
Molecular Plasticity of T Cells Informs Their Possible Adaptation in 4T1 TumorsMd Iftehimul, Robert H Newman, Scott H Harrison, et al.Biosensors|April 21, 2022
3D Printing in Solid Dosage Forms and Organ-on-Chip ApplicationsTarek Kassem, Tanoy Sarkar, Trieu Nguyen, et al.Microbiology Resource Announcements|August 11, 2025
Draft genomes of multidrug-resistant <i>Providencia manganoxydans</i> strains isolated from shrimp (<i>Penaeus monodon</i>) in BangladeshMd Iftehimul, Muhammad Tofazzal Hossain, Mohammad Mahfujul Haque, et al.Cancers|March 6, 2021
Pathogenetic Features and Current Management of GlioblastomaHong-My Nguyen, Kirsten Guz-Montgomery, Devin B Lowe, et al.Journal of Drug Targeting|April 7, 2023
Emerging biologics for the treatment of pulmonary arterial hypertensionTanvirul Hye, Md Riajul Hossain, Dipongkor Saha, et al.Seminars in Cancer Biology|May 25, 2021
Optimal timing of PD-1 blockade in combination with oncolytic virus therapyHong-My Nguyen, Praveen K Bommareddy, Ann W Silk, et al.Oncoimmunology|May 10, 2019
Triple combination immunotherapy with GVAX, anti-PD-1 monoclonal antibody, and agonist anti-OX40 monoclonal antibody is highly effective against murine intracranial gliomaNusrat Jahan, Hammad Talat, Andrea Alonso, et al.Journal of Neuro-Oncology|September 13, 2014
Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaLei Lu, Dipongkor Saha, Robert L Martuza, et al.Pageof 6